Search

Your search keyword '"Whaite, A."' showing total 281 results

Search Constraints

Start Over You searched for: Author "Whaite, A." Remove constraint Author: "Whaite, A."
281 results on '"Whaite, A."'

Search Results

1. Classification of variants of reduced penetrance in high-penetrance cancer susceptibility genes: Framework for genetics clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group-UK)

3. Meaningful and Measurable Health Domains in Huntington’s Disease: Large-Scale Validation of the Huntington’s Disease Health-Related Quality of Life Questionnaire Across Severity Stages

7. Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

10. Power Quality in DC Power Distribution Systems and Microgrids

11. Major ampullate silk gland transcriptomes and fibre proteomes of the golden orb-weavers, Nephila plumipes and Nephila pilipes (Araneae: Nephilidae).

12. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

13. Law and Practice in Spain

15. Summary of Findings of the National Reports

16. Law and Practice in the United Kingdom

17. Law and Practice in France

18. Law and Practice in Italy

19. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

20. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

22. The byssal-producing glands and proteins of the silverlip pearl oyster Pinctada maxima (Jameson, 1901)

23. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

32. Clinical and genetic characteristics of late-onset Huntington's disease

39. Secretory Gland Transcriptomics and Thread Proteomics for the Genus Nephila, Trichonephila and Pinctada

40. Classification of variants of reduced penetrance in high-penetrance cancer susceptibility genes: Framework for genetics clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group-UK)

41. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.

44. On the sequential determination of model misfit

45. Autonomous exploration: driven by uncertainty

46. Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study

48. Darboux frames, snakes, and super-quadrics: geometry from the bottom up

50. In vitro Diagnostic Medical Devices

Catalog

Books, media, physical & digital resources